The Naproxen Tablets, cataloged under National Stock Number 6505-01-200-2474, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Amneal Pharmaceuticals of New York, Llc. Government technical data includes 4 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-200-2474 |
| Primary Part Number | NDC53746-0190-01 |
| Item Name | Naproxen Tablets |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Amneal Pharmaceuticals of New York, Llc |
| Status | ACTIVE |
| Primary Container Content Quantity | 100.000 TABLETS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Active Medicament Medicinal Strength | 500.000 MILLIGRAMS NAPROXEN ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC53746-0190-01 PRIMARY | Amneal Pharmaceuticals of New York, Llc (USA) |
| NDC76282-0342-01 PRIMARY | Exelan Pharmaceuticals Inc Div Exelan Pharmaceuticals (USA) |
NSN 6505-01-200-2474 is a Naproxen Tablets, manufactured by Amneal Pharmaceuticals of New York, Llc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-200-2474 has 2 manufacturer part numbers on file: NDC53746-0190-01 (Amneal Pharmaceuticals of New York, Llc), NDC76282-0342-01 (Exelan Pharmaceuticals Inc Div Exelan Pharmaceuticals).
Key specifications for NDC53746-0190-01: Primary Container Content Quantity: 100.000 TABLETS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE; Part Name Assigned by Controlling Agency: NAPROXEN TABLETS USP 500 MG 100S. 4 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.